(Q50898958)

25 March 2018

title

Tailored second-line therapy in asthmatic children with the Arg(16) genotype. (English)

1 reference

25 March 2018

0 references

7

1 reference

25 March 2018

author name string

Brian J Lipworth

1

1 reference

25 March 2018

Kaninika Basu

2

1 reference

25 March 2018

Helen P Donald

3

1 reference

25 March 2018

Roger Tavendale

4

1 reference

25 March 2018

Donald F Macgregor

5

1 reference

25 March 2018

Simon A Ogston

6

1 reference

25 March 2018

Somnath Mukhopadhyay

8

1 reference

25 March 2018

language of work or name

English

0 references

publication date

1 April 2013

1 reference

25 March 2018

published in

Clinical Science

1 reference

25 March 2018

volume

124

1 reference

25 March 2018

issue

8

1 reference

25 March 2018

page(s)

521-528

1 reference

25 March 2018

The burden of asthma in the United States: level and distribution are dependent on interpretation of the national asthma education and prevention program guidelines.

cites work

1 reference

https://api.crossref.org/works/10.1042%2FCS20120528

Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120528

Adrenergic beta(2)-receptor genotype predisposes to exacerbations in steroid-treated asthmatic patients taking frequent albuterol or salmeterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120528

Arginine-16 beta2 adrenoceptor genotype predisposes to exacerbations in young asthmatics taking regular salmeterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120528

Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120528

The pharmacogenetics of beta2-adrenergic receptors: relevance to asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120528

Minimum skills required by children to complete health-related quality of life instruments for asthma: comparison of measurement properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120528

Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120528

Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120528

Beta2-receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionate

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120528

Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120528

Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120528

Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120528

The arginine-16 beta2-adrenoceptor polymorphism predisposes to bronchoprotective subsensitivity in patients treated with formoterol and salmeterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120528

β2-adrenoceptor polymorphisms and asthma from childhood to middle age in the British 1958 birth cohort: a genetic association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120528

Subsensitivity to bronchoprotection against adenosine monophosphate challenge following regular once-daily formoterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120528

Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120528

21 January 2018

Identifiers

DOI

10.1042/CS20120528

1 reference

25 March 2018

1 reference

25 March 2018